Awakn Life Sciences (TSE:AWKN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Awakn Life Sciences Corp., a biotechnology company focused on addiction therapeutics, has secured an unsecured credit facility of up to $535,000 to support its ongoing research and development projects. This financial move helps the company maintain its momentum in reaching new milestones, particularly in its lead programs AWKN-001 and AWKN-002 targeting mental health disorders.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.